In our study, the antibody titers were significantly higher in the survival group, and multivariate analysis showed that higher antibody titers (IgM and IgG) at 12 and 14 days after the onset of COVID-19 were associated with increased chance of survival. Here, CD40LG is linked to COVID-19.